Document Detail

Teratogenic effects of suramin on the chick embryo.
MedLine Citation:
PMID:  12592574     Owner:  NLM     Status:  MEDLINE    
Suramin, a polysulfonated naphthylamine, has been used for the chemotherapy of trypanosomiasis and onchocerciasis since about the 1920s. Currently, it is also being tested as an anticancer agent. It is hoped that suramin might stop the progression of some kinds of cancer since it has been found to inhibit the proliferation and migration of cells and the formation of new blood vessels. These processes are not only essential for the development and progression of cancer, but also for normal embryonic development. Suramin might, therefore, be a potent teratogen. In the literature, however, we have found only scant information on this subject. In the present study, we demonstrate the teratogenic effects of suramin on chick embryos. Suramin was injected into the coelomic cavity of chick embryos on incubation day (ID) 3. Following reincubation until ID 8, suramin-treated embryos ( n=50) were examined for congenital malformations and compared with a control group ( n=30). The survival rate of suramin-treated embryos was markedly reduced compared with controls (50% vs 90%). Among the 25 survivors the following malformations were recorded: caudal dysgenesia (100%), median facial clefts with hypertelorism (92%), malformations of the aortic arch arteries (88%), hypo-/aplasia of the allantoic vesicle (84%), microphthalmia (52%), abnormalities of the great arterial trunks (44%), unilateral or bilateral cleft lips (40%), heart defects with juxtaposition of the right atrial appendage (36%), persistence of the lens vesicle (32%), median clefts of the lower beak (8%), omphalocele (4%), and cloacal exstrophy (4%). These results show that suramin is a potent teratogen. The possible implications of our findings for human beings and the possible teratogenic mechanisms of suramin are discussed. Use of suramin in experimental teratology might help to clarify the morphogenesis of median facial clefts and of some congenital heart defects.
Jörg Männer; Wolfgang Seidl; Franziska Heinicke; Hagen Hesse
Related Documents :
17325254 - Pulmonary vascular disease in adults with congenital heart disease.
12959204 - Coronary arteries in crisscross heart.
23615104 - Endovascular web flow disruption in middle cerebral artery aneurysms: preliminary feasi...
11524324 - The assessment of the proximal left pulmonary artery by transesophageal echocardiograph...
7955574 - Relation between carotid artery atherosclerosis and time on dialysis. a non-invasive st...
18273564 - The content of elements in rainwater and its relation to the frequency of hospitalizati...
Publication Detail:
Type:  Journal Article     Date:  2003-01-18
Journal Detail:
Title:  Anatomy and embryology     Volume:  206     ISSN:  0340-2061     ISO Abbreviation:  Anat. Embryol.     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-19     Completed Date:  2003-09-26     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  7505194     Medline TA:  Anat Embryol (Berl)     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  229-37     Citation Subset:  IM    
Department of Embryology, Georg-August-University of Göttingen, Kreuzbergring 36, 37075, Göttingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Abnormalities / chemically induced,  pathology
Chick Embryo / abnormalities*,  drug effects*,  pathology
Digestive System Abnormalities
Eye Abnormalities / chemically induced
Head / abnormalities
Suramin / toxicity*
Survival Rate
Teratogens / toxicity*
Trypanocidal Agents / toxicity*
Reg. No./Substance:
0/Teratogens; 0/Trypanocidal Agents; 145-63-1/Suramin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mosaic evolution of neural development in anurans: acceleration of spinal cord development in the di...
Next Document:  Development of different mast cell types in the opossum Didelphis albiventris.